Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (MCK)
NYSE:MCK
MCK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$464.42 - $737.89
Previous CloseN/A
Volume137.88K
Average Volume (3M)878.90K
Market Cap
$85.41B
Enterprise Value$100.32B
Total Cash (Recent Filing)$2.68B
Total Debt (Recent Filing)$9.93B
Price to Earnings (P/E)27.4
Beta0.26
Next Earnings
Nov 04, 2025EPS Estimate
8.86Next Dividend Ex-Date
Sep 02, 2025Dividend Yield0.41%
Share Statistics
EPS (TTM)8.26
Shares Outstanding124,384,390
10 Day Avg. Volume855,657
30 Day Avg. Volume878,905
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.17
Enterprise Value/Revenue0.27
Enterprise Value/Gross Profit7.98
Enterprise Value/Ebitda19.33
Forecast
1Y Price Target
$791.38Price Target Upside15.25% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Bulls Say, Bears Say
Bulls Say
Business GrowthStrong first quarter results highlight McKesson's diversified exposure to rapidly growing parts of the healthcare supply chain.
Financial PerformanceMCK's FY1Q'26 results were fairly solid, with all three key segments coming in above consensus expectations on an adjusted EBIT basis.
Guidance IncreaseThe increase in McKesson's EPS guidance is attributed to operational strength across various segments, which is a modest positive for the company.
Bears Say
Competitive PerformancePeer COR's US Healthcare performance had more upside than MCK's US Pharma segment.
Stock PressureNot a blow-out, and could represent potential modest stock pressure given the dynamics of the results (and lack of significant upside), but underlying momentum still appears fairly solid.
McKesson News
MCK FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest stock price was $464.42 and its highest was $737.89 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $85.41B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Nov 04, 2025 which is in 64 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on Aug 06, 2025. The company reported $8.26 earnings per share for the quarter, beating the consensus estimate of $8.14 by $0.12.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $0.82 which represents an annual dividend yield of 0.41%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 8.86.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 124,384,390 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $8.26 in its last earnings report, beating expectations of $8.14. Following the earnings report the stock price went down -5.756%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Currently, no hedge funds are holding shares in MCK
McKesson Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$791.38 (15.25% Upside)
$791.38 (15.25% Upside)
Blogger Sentiment
Bullish
MCK Sentiment 87%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 342.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▲ 0.7%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.02%
12-Months-Change
Fundamentals
Return on Equity
51.23%
Trailing 12-Months
Asset Growth
13.45%
Trailing 12-Months
Company Description
Mckesson Corp.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
MCK Company Deck
MCK Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
McKesson's fiscal first quarter results were strong, with record revenue growth and increased full-year guidance, driven by robust segment performance and strategic acquisitions. However, the company faced challenges such as the impact of Rite Aid's bankruptcy and a decrease in international operating profit due to divestitures.View all MCK earnings summariesMCK Revenue Breakdown
91.27% U.S. Pharmaceutical
4.10% International
3.17% Medical-Surgical Solutions
1.45% Prescription Technology Solutions
MCK Stock 12 Month Forecast
Average Price Target
$791.38
▲(15.25% Upside)
Technical Analysis
Cencora
―
Cardinal Health
―
Henry Schein
―
Owens & Minor
―
Prestige Consumer Healthcare
―
Ownership Overview
0.05% Insiders
25.43% Mutual Funds
11.04% Other Institutional Investors
41.35% Public Companies and Individual Investors